Agenus (AGEN) Accumulated Expenses (2010 - 2026)
Agenus (AGEN) posted quarterly Accumulated Expenses of $37.0 million for Q1 2026, up 238.34% year-over-year from $10.9 million in Q1 2025, and up 309.78% quarter-over-quarter from $9.0 million in Q4 2025.
Analysis
Agenus (AGEN) Accumulated Expenses (2010 - 2026) Analysis & Trends
Agenus' Accumulated Expenses history runs 17 years deep, the most recent figure standing at $37.0 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 238.34% year-over-year to $37.0 million; the TTM figure through Mar 2026 stood at $37.0 million (up 238.34% YoY), while the FY2025 annual figure was $9.0 million, down 16.98% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $37.0 million, up from $9.0 million in the prior quarter.
- The five-year high for Accumulated Expenses was $41.3 million in Q1 2024, with the low at $6.5 million in Q1 2022.
- The 5-year median for Accumulated Expenses is $14.5 million (2023), against an average of $20.8 million.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses tumbled 79.2% in 2022, then surged 418.02% in 2023.
- Agenus' Accumulated Expenses stood at $15.9 million in 2022, then retreated by 8.57% to $14.5 million in 2023, then retreated by 25.08% to $10.9 million in 2024, then slipped by 16.98% to $9.0 million in 2025, then surged by 309.78% to $37.0 million in 2026.
- Business Quant data shows AGEN's Accumulated Expenses at $37.0 million in Q1 2026, $9.0 million in Q4 2025, and $31.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Agenus | 341.87 Mn | 341.87 Mn | 34.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.52 Mn |
| Mar 31, 2026 | 36.99 Mn |
| Dec 31, 2025 | 34.22 Mn |
| Sep 30, 2025 | 31.75 Mn |
| Jun 30, 2025 | 39.31 Mn |
| Mar 31, 2025 | 36.44 Mn |
| Dec 31, 2024 | 34.96 Mn |
| Sep 30, 2024 | 36.70 Mn |
| Jun 30, 2024 | 41.21 Mn |
| Mar 31, 2024 | 41.29 Mn |
| Dec 31, 2023 | 45.28 Mn |
| Sep 30, 2023 | 37.63 Mn |
| Jun 30, 2023 | 30.19 Mn |
| Mar 31, 2023 | 33.45 Mn |
| Dec 31, 2022 | 38.26 Mn |
| Sep 30, 2022 | 28.95 Mn |
| Jun 30, 2022 | 30.15 Mn |
| Mar 31, 2022 | 32.61 Mn |
| Dec 31, 2021 | 42.09 Mn |
| Sep 30, 2021 | 31.96 Mn |